Increased Pulmonary Embolism Incidence and Mortality in Patients Subsequently Diagnosed with COVID-19: An Analysis of Health Insurance Claims Data

Eur J Vasc Endovasc Surg. 2022 Jan;63(1):159-160. doi: 10.1016/j.ejvs.2021.08.027. Epub 2021 Sep 6.

Authors

Laura Acar¹, Frederik Peters², Ursula Marschall¹, Helmut L'Hoest¹, Chris Twine³, Christian-Alexander Behrendt⁴

Affiliations

¹ BARMER, Wuppertal, Germany.
² Department of Vascular Medicine, Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
³ Bristol Centre for Surgical Research, Bristol Medical School, University of Bristol, UK.
⁴ Department of Vascular Medicine, Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: behrendt@hamburg.de.

No abstract available

Keywords: COVID-19; Deep vein thrombosis; Health services research; Pulmonary embolism; SARS-CoV-2; Thromboembolism.

Publication types

Letter

MeSH terms

Aged
Anticoagulants / pharmacology
COVID-19 / complications
COVID-19 / diagnosis*
COVID-19 / epidemiology*
Female
Humans
Incidence
Insurance, Health / statistics & numerical data*
Male
Middle Aged
Pulmonary Embolism / epidemiology*
Pulmonary Embolism / mortality*
SARS-CoV-2 / pathogenicity
Venous Thromboembolism / complications
Venous Thromboembolism / mortality

Substances

Anticoagulants